301 related articles for article (PubMed ID: 29106711)
1. Interventions for treating central venous haemodialysis catheter malfunction.
Kennard AL; Walters GD; Jiang SH; Talaulikar GS
Cochrane Database Syst Rev; 2017 Oct; 10(10):CD011953. PubMed ID: 29106711
[TBL] [Abstract][Full Text] [Related]
2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
3. Interventions for treating catheter-related bloodstream infections in people receiving maintenance haemodialysis.
Almeida BM; Moreno DH; Vasconcelos V; Cacione DG
Cochrane Database Syst Rev; 2022 Apr; 4(4):CD013554. PubMed ID: 35363884
[TBL] [Abstract][Full Text] [Related]
4. Urgent-start peritoneal dialysis versus haemodialysis for people with chronic kidney disease.
Htay H; Johnson DW; Craig JC; Teixeira-Pinto A; Hawley CM; Cho Y
Cochrane Database Syst Rev; 2021 Jan; 1(1):CD012899. PubMed ID: 33501650
[TBL] [Abstract][Full Text] [Related]
5. Interventions for thrombosed haemodialysis arteriovenous fistulas and grafts.
Fonseca AV; Toledo Barros MG; Baptista-Silva JC; Amorim JE; Vasconcelos V
Cochrane Database Syst Rev; 2024 Feb; 2(2):CD013293. PubMed ID: 38353936
[TBL] [Abstract][Full Text] [Related]
6. Home versus in-centre haemodialysis for people with kidney failure.
Cheetham MS; Ethier I; Krishnasamy R; Cho Y; Palmer SC; Johnson DW; Craig JC; Stroumza P; Frantzen L; Hegbrant J; Strippoli GF
Cochrane Database Syst Rev; 2024 Apr; 4(4):CD009535. PubMed ID: 38588450
[TBL] [Abstract][Full Text] [Related]
7. Omega-3 fatty acids for dialysis vascular access outcomes in patients with chronic kidney disease.
Tam KW; Wu MY; Siddiqui FJ; Chan ES; Zhu Y; Jafar TH
Cochrane Database Syst Rev; 2018 Nov; 11(11):CD011353. PubMed ID: 30480758
[TBL] [Abstract][Full Text] [Related]
8. Peritoneal dialysis versus haemodialysis for people commencing dialysis.
Ethier I; Hayat A; Pei J; Hawley CM; Johnson DW; Francis RS; Wong G; Craig JC; Viecelli AK; Cho Y; Htay H; Ng S; Leibowitz S
Cochrane Database Syst Rev; 2024 Jun; 6(6):CD013800. PubMed ID: 38899545
[TBL] [Abstract][Full Text] [Related]
9. Catheter insertion techniques for improving catheter function and clinical outcomes in peritoneal dialysis patients.
Briggs VR; Jacques RM; Fotheringham J; Maheswaran R; Campbell M; Wilkie ME
Cochrane Database Syst Rev; 2023 Feb; 2(2):CD012478. PubMed ID: 36810986
[TBL] [Abstract][Full Text] [Related]
10. Psychosocial interventions for preventing and treating depression in dialysis patients.
Natale P; Palmer SC; Ruospo M; Saglimbene VM; Rabindranath KS; Strippoli GF
Cochrane Database Syst Rev; 2019 Dec; 12(12):CD004542. PubMed ID: 31789430
[TBL] [Abstract][Full Text] [Related]
11. Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.
von Groote TC; Williams G; Au EH; Chen Y; Mathew AT; Hodson EM; Tunnicliffe DJ
Cochrane Database Syst Rev; 2021 Nov; 11(11):CD004293. PubMed ID: 34778952
[TBL] [Abstract][Full Text] [Related]
12. Low protein diets for non-diabetic adults with chronic kidney disease.
Hahn D; Hodson EM; Fouque D
Cochrane Database Syst Rev; 2020 Oct; 10(10):CD001892. PubMed ID: 33118160
[TBL] [Abstract][Full Text] [Related]
13. Non-pharmacological interventions for preventing clotting of extracorporeal circuits during continuous renal replacement therapy.
Tsujimoto Y; Miki S; Shimada H; Tsujimoto H; Yasuda H; Kataoka Y; Fujii T
Cochrane Database Syst Rev; 2021 Sep; 9(9):CD013330. PubMed ID: 34519356
[TBL] [Abstract][Full Text] [Related]
14. Low protein diets for non-diabetic adults with chronic kidney disease.
Hahn D; Hodson EM; Fouque D
Cochrane Database Syst Rev; 2018 Oct; 10(10):CD001892. PubMed ID: 30284724
[TBL] [Abstract][Full Text] [Related]
15. Interventions for renal vasculitis in adults.
Walters GD; Willis NS; Cooper TE; Craig JC
Cochrane Database Syst Rev; 2020 Jan; 1(1):CD003232. PubMed ID: 31927782
[TBL] [Abstract][Full Text] [Related]
16. Antiplatelet agents for chronic kidney disease.
Natale P; Palmer SC; Saglimbene VM; Ruospo M; Razavian M; Craig JC; Jardine MJ; Webster AC; Strippoli GF
Cochrane Database Syst Rev; 2022 Feb; 2(2):CD008834. PubMed ID: 35224730
[TBL] [Abstract][Full Text] [Related]
17. Upper limb exercise for arteriovenous fistula maturation in people requiring permanent haemodialysis access.
Nantakool S; Reanpang T; Prasannarong M; Pongtam S; Rerkasem K
Cochrane Database Syst Rev; 2022 Oct; 10(10):CD013327. PubMed ID: 36184076
[TBL] [Abstract][Full Text] [Related]
18. Antimicrobial lock solutions for preventing catheter-related infections in haemodialysis.
Arechabala MC; Catoni MI; Claro JC; Rojas NP; Rubio ME; Calvo MA; Letelier LM
Cochrane Database Syst Rev; 2018 Apr; 4(4):CD010597. PubMed ID: 29611180
[TBL] [Abstract][Full Text] [Related]
19. Low molecular weight heparin for prevention of central venous catheter-related thrombosis in children.
Pelland-Marcotte MC; Amiri N; Avila ML; Brandão LR
Cochrane Database Syst Rev; 2020 Jun; 6(6):CD005982. PubMed ID: 32557627
[TBL] [Abstract][Full Text] [Related]
20. Low dialysate sodium levels for chronic haemodialysis.
Dunlop JL; Vandal AC; Marshall MR
Cochrane Database Syst Rev; 2019 Jan; 1(1):CD011204. PubMed ID: 30646428
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
